Market Research Logo

Global Cardiac Markers Market 2015-2019

Global Cardiac Markers Market 2015-2019

About cardiac markers

Cardiac markers are used for risk stratification and diagnosis of patients with suspected acute coronary syndrome and chest pain. Cardiac marker imaging is an effective, less expensive, and simple technique that helps a physician to decide whether the patient needs an invasive or complicated procedure. The cardiac marker testing is widely used in many medical settings especially for patients at low risk for cardiac death and patients with arteriosclerosis, conjunctive heart failure, sudden cardiac arrest, and myocardial infraction. The various types of cardiac markers are:

  • Troponin test
  • Creatine Kinase test
  • Lactate dehydrogenase
  • Aspartate transaminase
  • Myoglobin
  • Ischemia-modified albumin
  • Pro-brain natriuretic peptide
  • Glycogen phosphorylase isoenzyme BB
The other cardiac markers are C-reactive protein, homocysteine, pulmonary embolism (D-dimer test), and high-density and low-density lipoproteins.

Technavio's analysts forecast the global cardiac markers market to grow at a CAGR of 9.64% during 2014-2019.

Covered in this report

The report includes the present scenario and the growth prospects of the global cardiac markers market for 2015-2019. The market can be divided into the following segments:
  • By diagnosis facility: POC testing and laboratory testing
  • By assay type: Troponin I and BNP
Technavio's report, Global Cardiac Markers Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.

Key regions
  • Americas
  • APAC
  • EMEA
Key vendors
  • Abbott
  • Alere
  • Roche Diagnostics
  • Siemens Healthcare
Other prominent vendors
  • AniBiotech
  • Axis-Shield
  • Beckman Coulter
  • Becton, Dickinson and Company
  • BG Medicine
  • Biomerieux
  • Boston Scientific
  • Critical Diagnostics
  • diaDexus
  • LifeSign
  • Mitsubishi Chemical Europe
  • Nanomix
  • Radiometer Medical
  • Randox Laboratories
  • Response Biomedical
  • Sierra Resources International
  • Singulex
  • Thermo Fisher Scientific
  • Trinity Biotech
Key market driver
  • Early diagnosis and preventive medicine
  • For a full, detailed list, view our report
Key market challenge
  • Lack of specific actions for detection of cardiac disorders
  • For a full, detailed list, view our report
Key market trend
  • Increased usage of POC diagnostic tests
  • For a full, detailed list, view our report
Key questions answered in this report
  • What will the market size be in 2019 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?


Press Release

Technavio Announces the Publication of its Research Report – Global Cardiac Markers Market 2015-2019
Technavio recognizes the following companies as the key players in the Global Cardiac Markers Market: Abbott, Alere, Roche Diagnostics and Siemens Healthcare
Other Prominent Vendors in the market are: AniBiotech, Axis-Shield, Beckman Coulter, Becton, Dickinson and Company, BG Medicine, Biomerieux, Boston Scientific, Critical Diagnostics, diaDexus, LifeSign, Mitsubishi Chemical Europe, Nanomix, Radiometer Medical, Randox Laboratories, Response Biomedical, Sierra Resources International, Singulex, Thermo Fisher Scientific and Trinity Biotech
Commenting on the report, an analyst from Technavio’s team said: “POC diagnostic tests provide immediate results, which lead to instant treatment decisions. These tests are the preferred tools for diagnosis and are gaining popularity in patient treatment evaluation. Currently, the tests that are based on lateral flow immunoassays are also available for haemoglobin testing, pregnancy testing, food pathogen screening, faecal occult blood analysis, myocardial infraction, cholesterol testing, infectious disease testing, and blood glucose testing. POC tests act as a catalyst for the development of preventive medicine because of rapid tests results and a high level of accuracy.”
According to the report, hospitals and other healthcare centers are required to reduce healthcare spending without compromising the quality of treatment and by improving patient outcomes. This can be done with the early diagnosis of cardiac disorders, which allows physicians to take care of patients during the early stages, avoiding the need for hospital stays. Cardiac markers offer reliable and efficient disease diagnosis because of high-sensitivity test kits, short turnaround time, high productivity, and easy operation of instruments. This helps in maintaining quality and reducing the costs of healthcare services.
Further, the report states lack of specific actions for detection of cardiac disorders is affecting the market growth.

Companies Mentioned

Abbott, Alere, Roche Diagnostics, Siemens Healthcare, AniBiotech, Axis-Shield, Beckman Coulter, Becton, Dickinson and Company, BG Medicine, Biomerieux, Boston Scientific, Critical Diagnostics, diaDexus, LifeSign, Mitsubishi Chemical Europe, Nanomix, Radiometer Medical, Randox Laboratories, Response Biomedical, Sierra Resources International, Singulex, Thermo Fisher Scientific, Trinity Biotech

  • Executive summary
    • Highlights
  • Scope of the report
    • Market overview
    • Top-vendor offerings
      • Table Product offerings
  • Market research methodology
    • Research methodology
    • Economic indicators
  • Introduction
    • Key market highlights
  • Cardiac markers overview
    • Table Cardiac marker tests and their respective cost savings
    • Table Characteristics of cardiac markers
    • Table Segmentation of global cardiac markers market by disease applications 2014
  • Market landscape
    • Market overview
      • Table Global cardiac markers market segmentation
    • Market size and forecast
      • Table Global cardiac markers market 2014-2019 ($ billions)
    • Five forces analysis
      • Table Five forces analysis
  • Market segmentation by assay type
    • Table Segmentation of global cardiac markers market by assay type
    • Table Segmentation of global cardiac markers market by assay type 2014
    • Table Segmentation of global cardiac markers market by assay type 2019
    • Table Segmentation of global cardiac markers market by assay type 2014-2019
    • Global troponin I market
      • Table Global troponin I market 2014-2019 ($ billions)
    • Global BNP market
      • Table Global BNP market 2014-2019 ($ millions)
  • Market segmentation by diagnostic facility
    • Table Segmentation of global cardiac markers market by diagnostic facility
    • Table Segmentation of global cardiac markers market by diagnosis facility 2014
    • Table Segmentation of global cardiac markers market by diagnostic facility 2019
    • Table Segmentation of global cardiac markers market by diagnostic facility 2014-2019
    • Global cardiac POC testing market
      • Table Global cardiac POC testing market 2014-2019 ($ millions)
      • Table Segmentation of global cardiac POC testing market by assay type
      • Table Global troponin I market in POC setting 2014-2019 ($ millions)
      • Table Global BNP market in POC setting 2014-2019 ($ millions)
      • Table Segmentation of global cardiac POC testing market by geography 2014
    • Global cardiac laboratory testing market
      • Table Global cardiac laboratory testing market 2014-2019 ($ billions)
      • Table Segmentation of global cardiac laboratory testing market by assay type
      • Table Global troponin I market in laboratory setting 2014-2019 ($ millions)
      • Table Global BNP market in laboratory setting 2014-2019 ($ millions)
      • Table Segmentation of global cardiac laboratory testing market by geography 2014
  • Geographical segmentation
    • Geographical segmentation of global cardiac markers market
      • Table Segmentation of global cardiac markers market by geography 2014
      • Table Segmentation of global cardiac markers market by geography 2019
      • Table Segmentation of global cardiac markers market by geography 2014-2019
    • Cardiac markers market in Americas
      • Table Cardiac markers market in Americas 2014-2019 ($ billions)
    • Cardiac markers market in EMEA
      • Table Cardiac markers market in EMEA 2014-2019 ($ millions)
    • Cardiac markers market in APAC
      • Table Cardiac markers market in APAC 2014-2019 ($ millions)
  • Market drivers
  • Impact of drivers
    • Table Impact of drivers
  • Market challenges
  • Impact of drivers and challenges
    • Table Impact of drivers and challenges
  • Market trends
  • Vendor landscape
    • Competitive scenario
    • Market share analysis 2014
      • Table Abbott: Key takeaways
      • Table Alere: Key takeaways
      • Table Roche Diagnostics: Key takeaways
      • Table Siemens Healthcare: Key takeaways
    • Other prominent vendors
  • Key vendor analysis
    • Abbott Diagnostics
      • Table Abbott Diagnostics: Key business offerings
    • Alere
      • Table Alere: Business segmentation by revenue 2014
      • Table Alere: Business segmentation by revenue 2013 and 2014 ($ millions)
      • Table Alere: Geographical segmentation by revenue 2013 and 2014 ($ millions)
    • Roche Diagnostics
    • Siemens Healthcare
  • Appendix
    • List of abbreviations
  • Explore Technavio

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report